188 related articles for article (PubMed ID: 19389413)
21. Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury.
El-Assal ON; Besner GE
Semin Pediatr Surg; 2004 Feb; 13(1):2-10. PubMed ID: 14765365
[TBL] [Abstract][Full Text] [Related]
22. Effect of chronic and selective endothelin receptor antagonism on microvascular function in type 2 diabetes.
Sachidanandam K; Elgebaly MM; Harris AK; Hutchinson JR; Mezzetti EM; Portik-Dobos V; Ergul A
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2743-9. PubMed ID: 18424628
[TBL] [Abstract][Full Text] [Related]
23. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats.
Du QH; Han L; Jiang JJ; Xu Y; Li WH; Li PT; Wang XY; Jia X
World J Gastroenterol; 2014 Nov; 20(44):16674-82. PubMed ID: 25469036
[TBL] [Abstract][Full Text] [Related]
24. Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis.
Radulescu A; Yu X; Orvets ND; Chen Y; Zhang HY; Besner GE
J Pediatr Surg; 2010 Apr; 45(4):729-34. PubMed ID: 20385279
[TBL] [Abstract][Full Text] [Related]
25. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
Feng J; El-Assal ON; Besner GE
J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
[TBL] [Abstract][Full Text] [Related]
26. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-1 impairs coronary arteriolar dilation: Role of p38 kinase-mediated superoxide production from NADPH oxidase.
Thengchaisri N; Hein TW; Ren Y; Kuo L
J Mol Cell Cardiol; 2015 Sep; 86():75-84. PubMed ID: 26211713
[TBL] [Abstract][Full Text] [Related]
28. Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes.
Chen CL; Mehta VB; Zhang HY; Wu D; Otabor I; Radulescu A; El-Assal ON; Feng J; Chen Y; Besner GE
Growth Factors; 2010 Apr; 28(2):82-97. PubMed ID: 19939201
[TBL] [Abstract][Full Text] [Related]
29. Heparin-binding EGF-like growth factor decreases inducible nitric oxide synthase and nitric oxide production after intestinal ischemia/reperfusion injury.
Xia G; Lara-Marquez M; Luquette MH; Glenn S; Haque A; Besner GE
Antioxid Redox Signal; 2001 Oct; 3(5):919-30. PubMed ID: 11761337
[TBL] [Abstract][Full Text] [Related]
30. Heparin-binding epidermal growth factor-like growth factor downregulates expression of activator protein-1 transcription factor after intestinal ischemia-reperfusion injury.
Luo CC; Ming YC; Chao HC; Chu SM; Pang ST
Neonatology; 2011; 99(4):241-6. PubMed ID: 21063128
[TBL] [Abstract][Full Text] [Related]
31. Acute modulation of vasoconstrictor responses by pravastatin in small vessels.
Ghaffari N; Ball C; Kennedy JA; Stafford I; Beltrame JF
Circ J; 2011; 75(6):1506-14. PubMed ID: 21532183
[TBL] [Abstract][Full Text] [Related]
32. HB-EGF improves intestinal microcirculation after hemorrhagic shock.
Zhang HY; Radulescu A; Chen Y; Besner GE
J Surg Res; 2011 Nov; 171(1):218-25. PubMed ID: 20421109
[TBL] [Abstract][Full Text] [Related]
33. Heparin-binding epidermal growth factor-like growth factor protects rat intestine after portal triad clamping.
Liao X; Chen L; Fu W; Zhou J
Growth Factors; 2013 Apr; 31(2):74-80. PubMed ID: 23534509
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor.
Mehta VB; Besner GE
J Immunol; 2003 Dec; 171(11):6014-22. PubMed ID: 14634113
[TBL] [Abstract][Full Text] [Related]
35. Heparin-binding EGF-like growth factor promotes neuronal nitric oxide synthase expression and protects the enteric nervous system after necrotizing enterocolitis.
Zhou Y; Wang Y; Olson J; Yang J; Besner GE
Pediatr Res; 2017 Sep; 82(3):490-500. PubMed ID: 28422949
[TBL] [Abstract][Full Text] [Related]
36. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) protected intestinal ischemia-reperfusion injury through JNK and p38/MAPK-dependent pathway for anti-apoptosis.
Ming YC; Chao HC; Chu SM; Luo CC
Pediatr Neonatol; 2019 Jun; 60(3):332-336. PubMed ID: 30455099
[TBL] [Abstract][Full Text] [Related]
37. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) preserves gut barrier function by blocking neutrophil-endothelial cell adhesion after hemorrhagic shock and resuscitation in mice.
Zhang HY; James I; Chen CL; Besner GE
Surgery; 2012 Apr; 151(4):594-605. PubMed ID: 22153812
[TBL] [Abstract][Full Text] [Related]
38. Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation.
Bohlen HG; Zhou X; Unthank JL; Miller SJ; Bills R
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1337-46. PubMed ID: 19666847
[TBL] [Abstract][Full Text] [Related]
39. M1 to M2 macrophage polarization in heparin-binding epidermal growth factor-like growth factor therapy for necrotizing enterocolitis.
Wei J; Besner GE
J Surg Res; 2015 Jul; 197(1):126-38. PubMed ID: 25913486
[TBL] [Abstract][Full Text] [Related]
40. HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.
Fontaine JT; Rosehart AC; Joutel A; Dabertrand F
Mech Ageing Dev; 2020 Dec; 192():111389. PubMed ID: 33127441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
